LivaNova reports Q3 adjusted EPS 90c, consensus 72c

Reports Q3 revenue $318.1M, consensus $300.49M. “LivaNova (LIVN) delivered strong revenue and operating income growth in the Q3,” said Vladimir Makatsaria, CEO of LivaNova. “This performance reflects the strength of our team’s ongoing execution and steadfast commitment to serving customers and their patients. We look forward to building on this momentum in the Q4 and in 2025, driven by our continued focus on performance, innovation, and talent.”